Filing Details
- Accession Number:
- 0001209191-17-061769
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-20 16:25:24
- Reporting Period:
- 2017-11-16
- Accepted Time:
- 2017-11-20 16:25:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236927 | A Paul Friedman | 1801 Augustine Cut-Off Wilmington DE 19803 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-11-16 | 28,507 | $105.24 | 269,011 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The reporting person contributed Incyte Common Stock on November 16, 2017 to an exchange fund in exchange for limited partnership units of the exchange fund. The Incyte Common Stock was valued at $105.24 per share for the purpose of determining the number of limited partnership units of the exchange fund issuable to the reporting person.
Billionaire Hedge Funds
